Continental Chemicals Board of Directors

Get the latest insights into the leadership at Continental Chemicals. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Pradeep Kumar Chopra Chairman & Ind.Director
Mr. Naresh Kumar Chibba Managing Director
Mr. Akshat Bhaskar Independent Director
Ms. Sunaina Chibba Director
Mr. Aditya Vikram Chibba Director

Continental Chemicals Share price

CONTCHM

75.25

0.37 (-0.49%)
Last updated on 4 Sep, 2025 | 09:07 IST
BUYSELL
Today's High

75.25

Today's Low

75.25

52 Week Low

64.75

52 Week High

119.99

The current prices are delayed, login to your account for live prices

Continental Chemicals FAQs

The board at Continental Chemicals consists of experienced professionals, including Mr. Pradeep Kumar Chopra , Mr. Naresh Kumar Chibba , and others, overseeing the company’s strategic and corporate governance.

Directors at Continental Chemicals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Pradeep Kumar Chopra is the current chairman at Continental Chemicals.

Executive directors at Continental Chemicals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Continental Chemicals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Continental Chemicals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.